Skip to main content

HEALTH

  • Strativa enters license, supply agreement with Sobi

    WOODCLIFF LAKE, N.J. Strativa Pharmaceuticals is working with a Swedish drug maker to develop and commercialize a prescription vitamin supplement, Strativa said Tuesday.

     

    The company said it had signed a license and supply agreement with Swedish Orphan Biovitrum, also known as Sobi, concerning European rights to Strativa’s Nascobal (cyanocobalamin), a vitamin B12 nasal spray.

     

     

  • Surescripts launches open platform for docs

    NEW ORLEANS Opening another front in its long campaign to extend electronic prescribing and health information technology throughout the United States, e-prescribing platform provider Surescripts said Monday that it will expand its nationwide e-prescribing network to accelerate the digital transformation of the nation’s healthcare system by enabling the electronic exchange of all types of clinical information.

  • Merlot Skin Care to expand offerings, update packaging

    EL PASO, Texas Merlot Skin Care, a natural grape-seed-based skin care brand sold at Walgreens and Ulta, is celebrating its 10-year anniversary in 2011 with new product launches and new packaging.

    "Merlot is a brand that knows the power of natural grape-seed antioxidants can be used to achieve beautiful skin," stated Wayne Beckley, founder and CEO of Merlot Skin Care."We are proud that our moisturizer has become a staple of so many women's daily beauty routines."

     

  • Cirrus' ClearEars can relieve glue ear

    COLD SPRING HARBOR, N.Y. Cirrus Healthcare Products recently announced the launch of ClearEars, earplugs that contain a polymer to draw water from the ears after water activities. Consumers with glue ear, a condition in which thick, sticky fluid collects behind the eardrum, discovered that ClearEars helps to alleviate this condition, the company said.

     

  • Study: Consumers stay loyal to Tylenol, despite recent McNeil problems

    PHILADELPHIA —According to a recent study released by the Relational Capital Group, consumer purchase intent and brand loyalty for Tylenol still is high despite the recent spate of Tylenol product recalls. According to the study, 76% of consumers reported positive purchase intent, and 67% reported positive brand loyalty for Tylenol.

X
This ad will auto-close in 10 seconds